Sponsored By


 

Eczema, wheeze at one year
not linked to early vaccines.


Life events that cause stress
may affect asthma
quality of life.

 
  
Feb. 28, 2007
  
Welcome to ACAAI eNews — a bi-weekly aggregated news service from the American College of Allergy, Asthma & Immunology. To be removed from this distribution list, please see instructions at bottom.
 
Top Stories
 
Distance Learning
   
Drugs and Devices
   
Association News
   
Fellows-in-Training
   
Periodicals
Calendar
   
Archive
FIT Archive
Members:
update 
e-mail address
here
  
Non-members:
subscribe here

 

ACAAI Home
 
 

Distance Learning
ACAAI Podcast/Vodcast Library
Link
 
Periodicals
Annals of Allergy, Asthma and Immunology
Current issue

• AllergyWatch
Current issue
 
Calendar

MARCH
IX International Symposium on Respiratory Viral Infections
The Macrae Group
March 3 - 6, Causeway Bay, Hong Kong
Tel: (+1) 212.988.7732
E-mail
Link

APRIL
2007 World Immune Regulation Meeting
April 11-15, 2007
Davos, Switzerland
Email
Link

Allergy and Clinical Immunology (65th Annual Course)
University of Minnesota
April 20, Minneapolis, Minn.
Tel: 612-626-7600 or 800-776-8636
E-mail
Link

International Conference on Asthma Impacts of Air Pollution

South Coast Air Quality Management District
April 26-27, Anaheim, CA
Tel: 909-396-2432
Link

JUNE
2007 Annual Meeting of the Florida Allergy, Asthma & Immunology Society
June 8-10, Sarasota, Fla.
Tel: 904-765-7702

2nd World Congress on Work-Related and Environmental Allergy / 6th International Symposium on Irritant Contact Dermatitis
June 13-16, Weimar, Germany
Tel: 49-0-3641-35-330
Email
Link 

JULY
2007 International Congress on Respiratory Viruses
The Macrae Group
July 20-22, Colorado Springs, Colo.
Tel: 212-988-7732
E-mail 
Link

25th Annual Aspen Allergy Conference
July 24-28, Aspen, CO
Conference Coordinator: Jill Hibbeln
Tel: 720-384-5917
E-mail
Link


ONGOING
World Allergy Organization Society Meetings

ACAAI CME Website
Contact: Mary Campbell
Tel: 847-427-1200
E-mail

 Sponsored By

 
  
Top Stories
 
Eczema, wheeze at one year not tied to early vaccines
Vaccinations during a child’s first 6 months, such as diphtheria, pertussis, poliomyelitis, tetanus, and Haemophilus influenzae type b, seem to have little effect on the development of eczema or recurrent wheeze at one year, according to a study in Pediatrics. The study’s authors analyzed data from 2,545 infants participating in the KOALA Birth Cohort Study in the Netherlands, looking for eczema or recurrent wheeze in infants who received standard, incomplete, or no vaccinations. Of the infants included in the study, 7 percent were never vaccinated, 15 percent received an incomplete schedule and 77 percent received a standard schedule. No statistically significant difference was seen in occurrence of eczema and recurrent wheeze among the groups.

Stressful life events may affect asthma quality of life
Emotional events that cause stress, such as divorce or the death of a loved one, may affect asthma quality of life, especially among asthmatics with lower incomes, according to a study in Thorax. Scientists at the University of California, San Francisco, followed 189 adults with asthma, using standard questionnaires, lung function tests, and blood tests to measure cotinine, reflecting exposure to tobacco smoke. Subjects’ asthma-related quality of life declined as their number of recent stressful events increased.

FDA requests new warnings on Xolair labels
The Food and Drug Administration recently announced its request that Genentech Inc. add a boxed warning to the product label for omalizumab, marketed as Xolair. The boxed warning would emphasize that Xolair may cause anaphylaxis. In addition, the FDA also asked Genentech to revise the Xolair label and provide a medication guide for patients to strengthen the existing warning for anaphylaxis. The strengthened warning includes the possibility of a patient developing anaphylaxis after any dose of Xolair, even if there was no reaction to the first dose. Following administration of Xolair, patients should carry and know how to initiate emergency self-treatment for anaphylaxis. 


COPD patients benefit from salmeterol, fluticasone propionate
Patients with COPD can benefit from salmeterol and fluticasone propionate treatment, including less frequent COPD-related exacerbations, significantly improved quality of life and improved lung function, according to a study in the New England Journal of Medicine. British researchers during the Towards a Revolution in COPD Health, or TORCH, study followed 6,112 COPD patients for three years, comparing subjects receiving combination therapy, salmeterol alone, fluticasone propionate alone, and placebo. Combination therapy reduced by 25 percent (compared with placebo) COPD-related exacerbations — defined as the worsening of symptoms requiring systemic steroids, antibiotics, or hospitalizations. Taking both salmeterol and fluticasone propionate also reduced subjects’ risk of death by 17.5 percent over three years compared to patients taking placebo. 
 
A message from ACAAI President Dr. Daniel Ein

ACAAI members will get a taste of Texas hospitality during the 2007 Annual Meeting at the Gaylord Texan Resort. On my recent visit to Dallas, the Gaylord proved itself to be a great destination for
meetings.

The complex includes a large, self-contained convention center with excellent meeting facilities, lots of good restaurants and comfortable hotel rooms — all adjacent to the meeting area. In fact, everything is in close proximity and extremely convenient. (One of the criticisms I heard about the Philadelphia meeting was that the major sessions in the Pennsylvania Convention Center were too far from the rooms.)

You won’t forget you’re in Texas. The Lone Star is ubiquitous in the hotel’s décor — on the floors, walls, and ceilings. Longhorn cattle busts jut from the external walls, and Tex-Mex cuisine and all things beef are well-represented — and delicious.

You’ll find excellent workout facilities and jogging trails, as well as two first-rate golf courses within five minutes of the hotel. And for those of you who like nightlife, the Glass Cactus nightclub is open Tuesday through Saturday evenings for dancing.

If you or your guests want to get in a little shopping, the hotel offers regular shuttle service to several nearby malls. The Alliance is planning outings to downtown Dallas to see the JFK Museum and associated sights, including the “grassy knoll” and the Texas School Book Depository. Dallas also offers several good museums. And, in nearby Ft. Worth, you’ll find more world-class museums and a charming old Western district with first-class dining and nightlife.

The Program Committee, chaired by Dr. Jay Portnoy, is looking at many new and exciting sessions, so I have no doubt that this fall’s meeting will continue the College’s tradition of first-class learning opportunities.

Watch for more information about the meeting in the months ahead. I am excited about how it is shaping up, and I hope you will be, too.
 
Call for action: submit your comments on the NHLBI guidelines
by March 5

As you may know, the draft document, Full Report of Expert Panel: Guidelines for the Diagnosis and Management of Asthma (EPR-3), has been posted on the NHLBI Web site for public review and comment by no later than Monday, March 5, 2007.

Drs. Ira Finegold and Linda Cox have prepared comments which have been approved by your College and which it will submit to NHLBI for the record. The ACAAI comments are available on the College Web site. Please feel free to consult these notes for your own comments.

“The Executive Committee of the College is concerned that immunotherapy is not adequately presented as a bona fide treatment for asthma,” said ACAAI President Dr. Daniel Ein. “There is a section on immunotherapy to be found on page 148 of the document and some other mentions of it elsewhere.

“If, however, one looks at the proposed treatment steps in the tables for management of asthma, there is no mention of immunotherapy. (Look at Figure 4-5 on page 517 in Component 2 of the document). This is particularly troublesome because most of the readers of the guidelines will only look at the tables and this is where immunotherapy needs to be included. Other glaring omissions are documented in our official response,” he said.

We strongly urge you to send your individual comments to NHLBI to point out the shortcomings in the document. All comments must be submitted electronically by March 5 using the “review and comment form” on the NHLBI Web site. The URL is: http://www.nhlbi.nih.gov/guidelines/asthma/epr3
 
Association News
 

The College partners with ReachMD
on content for new XM Satellite Radio physicians’ channel

In collaboration with ReachMD, the College will pilot a weekly show to be aired on the new satellite radio channel for physicians. ReachMD, scheduled to launch this spring, is the only 24/7 radio channel for clinicians, providing talk, news, and education.

“We are pleased to announce that ReachMD of XM Satellite Radio has identified the College for the relevance of its content across the entire medical community,” said ACAAI President Dr. Daniel Ein. “ReachMD provides the perfect platform for the medical community to exchange ideas with busy, practicing clinicians to improve patient care.”

The College’s weekly show will highlight articles in Annals of Allergy, Asthma & Immunology and AllergyWatch in short format 15-minute sessions. Content from Annual Meeting programs such as the Literature Review Course and the Food Allergy Symposium may also be adapted to upcoming programs.

XM Satellite Radio is America’s number one satellite radio company with more than 7.6 million subscribers. Some 170 digital channels of sports, news, talk, and commercial-free music are beamed directly from three powerful satellites to cars, homes, and hand-held portable receivers nationwide.

Look for more information on the launch of ReachMD on XM Satellite Radio in future issues of ACAAI eNews and ACAAI News.

Register for the Nationwide Asthma Screening Program by March 15
You can bring the Nationwide Asthma Screening Program to your community to educate the public about the diagnosis and treatment of asthma and position allergists as specialists who treat asthma.

The program, supported by AstraZeneca, has screened more than 100,000 people and about half have been referred for a professional diagnosis. Most of the 300 screening days each year are conducted in May as part of National Asthma and Allergy Awareness Month. May also is the time the College conducts national media relations to publicize the screening program.

The deadline for registration for the 2007 program is March 15. For more information, visit the College member Web site or call the screening program Help Line at (312) 558-1175.

College members considering a screening program for their community can access background information online with answers to frequently asked questions about the program and tips about site selection and partnering with patient support groups. While visiting the Web site, allergists can download a Screening Program Coordinator Registration form for the program.

New features enhance ACAAI Job Source online service
The ACAAI Job Source -- service for posting and searching employment opportunities within the specialty has been upgraded with many new features.

Job seekers can continue to access the Job Source at no cost to search employment opportunities and to post their resumes for advertised positions. The new system requires previous users to complete a new candidate profile. An anonymous resume feature enables you to list your experience and qualifications in a protected environment.

A new Job Alert system notifies you by e-mail when a new job has been posted that matches your search criteria. Other program enhancements allow you to save searches, store jobs in an account, keep notes on job opportunities, and communicate with employers using an internal messaging system. Candidates stay connected to the employment market while maintaining full control of their confidential information.

Employers can purchase an ad for their available position. When making your purchase, you have the option to pay online with a credit card or to be invoiced. Your account will allow you to post and manage job openings, search and manage job candidates, and create a company profile.

The Job Source includes all categories of Allergy, Asthma and Immunology personnel, including physicians, program directors, investigators, laboratory technicians, nurses, and administrators.

Members in the spotlight
Congratulations to Dr. Mark Stein, North Palm Beach, Fla., for receiving the 2007 “Man of the Year” award from National Jewish Medical and Research Center in Denver. Dr. Stein will receive his award at a luncheon on March 22 at the Kravis Center in West Palm Beach, Fla.

If you would like to help honor him, contact Lauren Wahl at the National Jewish Regional Office at (561) 477-5400.

Have you won a prestigious award? Have you written a new book? Are you doing something that ACAAI members would really find interesting? Submit notable achievements and read about those of your peers in ACAAI eNews. Please e-mail member news notices to joannfaber@acaai.org.

 
Fellows-in-Training
 
Did you know the FITs have their own list serve? By joining, you can participate in an ongoing discussion among fellows-in-training across the nation and around the world. Offer a comment. Ask or answer a question. Start a discussion. You can register online. Once registered, you can send a message at any time to the members of the list serve.

To access the list service, find news and announcements for fellows-in-training and a list of your national and regional representatives, visit the FITs Web site.
 

Board Review Corner
The Board Review Corner, prepared by Dr. Soo Kim-Delio, senior representative of ACAAI’s fellows-in-training (FITs) to the Board of Regents, will continue with the next issue of ACAAI eNews.

To refer to a previous Board Review Corner, click the “FIT Archive” link in the left column.


Copyright © 2007 American College of Allergy, Asthma & Immunology. All rights reserved.

E-newsletter services provided by the medical editors at Ascend Media, LLC.

Do you have news, responses or opinions to share with us? Please e-mail the association office at enews@acaai.org
  
THIS E-MAIL WAS SENT FROM A “SEND-ONLY” MAILBOX. Please DO NOT REPLY to this e-mail.
ACAAI eNews is sent as a membership benefit of the American College of Allergy, Asthma & Immunology. If you would prefer not to receive future issues and want to remove your name from our mailing list, please -click here-